10-Q Filing

XILIO THERAPEUTICS, INC. CIK: 1840233 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001558370-22-012756`
Period End Date	20220630
Filing Date	20220809
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	xlo-20220630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 50 Cash Flow Statement 49 Stockholders Equity 26

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$159.41M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.30M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$198.05M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.60M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.46M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$163.01M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$202.52M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.55M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.55M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.55M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.62M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.79M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.98M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$393.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$335.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.39M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.36M	shares	Point-in-time
Total assets	`Assets`	$178.13M	USD	Point-in-time
Total assets	`Assets`	$218.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.41M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.14M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.75M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.09M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$801.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$858.00K	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$3.33M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.77M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$9.63M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$6.39M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$9.66M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$10.11M	USD	Point-in-time
Other liabilities, long-term	`OtherLiabilitiesNoncurrent`	$118.00K	USD	Point-in-time
Other liabilities, long-term	`OtherLiabilitiesNoncurrent`	$82.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$32.63M	USD	Point-in-time
Total liabilities	`Liabilities`	$33.91M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding at June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding at June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at June 30, 2022 and December 31, 2021; 27,471,607 shares issued and 27,391,834 shares outstanding at June 30, 2022; 27,468,950 shares issued and 27,358,375 shares outstanding at December 31, 2021	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at June 30, 2022 and December 31, 2021; 27,471,607 shares issued and 27,391,834 shares outstanding at June 30, 2022; 27,468,950 shares issued and 27,358,375 shares outstanding at December 31, 2021	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$351.07M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$346.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-206.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-160.89M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$144.22M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$166.12M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$185.43M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-99.14M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-121.31M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$218.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$178.13M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$29.37M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$31.17M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$17.75M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$16.25M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$10.16M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.31M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.26M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$14.61M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$24.55M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$45.78M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$39.53M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-24.55M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.01M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-39.53M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-45.78M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-174.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-321.00K	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-61.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-190.00K	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-190.00K	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-321.00K	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-61.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-174.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-45.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.61M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-23.18M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-24.61M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-39.85M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-45.97M	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.90	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.68	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-31.48	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-55.16	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-55.16	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.68	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.90	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-31.48	USD	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.38M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.38M	shares	2 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	722,424.00	shares	2 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	736,473.00	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	736,473.00	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.38M	shares	2 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.38M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	722,424.00	shares	2 Qtrs

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-45.97M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-39.85M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$885.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$723.00K	USD	2 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$106.00K	USD	2 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$78.00K	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$1.80M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.74M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-19.00K	USD	2 Qtrs
Change in fair value of warrant and derivative liabilities	`FairValueAdjustmentsOfWarrantsAndDerivativeLiabilities`	$44.00K	USD	2 Qtrs
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-857.00K	USD	2 Qtrs
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.40M	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-188.00K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-159.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.92M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.22M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.20M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-6.16M	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-386.00K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-205.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-37.59M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-42.87M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$608.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.02M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-608.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.02M	USD	2 Qtrs
Repayments of debt principal	`RepaymentsOfDebt`	$333.00K	USD	2 Qtrs
Payments of finance lease	`FinanceLeasePrincipalPayments`	$42.00K	USD	2 Qtrs
Payments of finance lease	`FinanceLeasePrincipalPayments`	$42.00K	USD	2 Qtrs
Proceeds from issuance of convertible preferred stock, net of issuance costs	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$144.89M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$30.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$16.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$144.54M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-26.00K	USD	2 Qtrs
(Decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-38.64M	USD	2 Qtrs
(Decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$101.06M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.85M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$160.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.79M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.79M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$160.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.85M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$240.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$253.00K	USD	2 Qtrs
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$154.00K	USD	2 Qtrs
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$2.00K	USD	2 Qtrs
Deferred offering costs included in accounts payable or accrued expenses	`DeferredOfferingCostsIncludedInAccountsPayableOrAccruedExpenses`	$1.54M	USD	2 Qtrs

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$144.22M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-99.14M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-121.31M	USD	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$25.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2,657.00	shares	2 Qtrs
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$794.00K	USD	1 Quarter
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.71M	USD	1 Quarter
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.03M	USD	1 Quarter
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.00M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-45.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$-99.14M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$144.22M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-121.31M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.